EO2002
Phase 1Biologic
EO2002 is one of 5 biologic programs targeting Corneal Edema. It is currently in Phase 1.
1
Indications
3
Total Trials
2
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
11 competitors in Corneal Edema
#DrugCompanyPhaseTrials
1Kenalog
BBassett Healthcare
Approved
Decadron
AAspen Global Incorporated
Approved
Alphagan
AbbViePhase 3
Rhopressa
FFalcon
Phase 2
EO2002
AAsociación para Evitar la Ceguera en México
Phase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for EO2002. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details